相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting group II PAKs in cancer and metastasis
Jeyanthy Eswaran et al.
CANCER AND METASTASIS REVIEWS (2009)
Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome
Christy W. H. Au et al.
CANCER LETTERS (2009)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer
Xiaohui Yu et al.
CANCER SCIENCE (2008)
Targeted drug delivery via folate receptors
Xiaobin Zhao et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Targeting TrkB neurotrophin receptor to treat depression
Tomi Rantamäki et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
A phase I trial of CEP-701+gemcitabine in patients with advanced adenocarcinoma of the pancreas
Emily Chan et al.
INVESTIGATIONAL NEW DRUGS (2008)
Angiogenesis as a strategic target for ovarian cancer therapy
Whitney A. Spannuth et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway
Zhijie Li et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Inactivation of glycogen synthase kinase-3β contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells
Zhijie Li et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: Role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase
Hong Y. Zhou et al.
ENDOCRINOLOGY (2007)
Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death
Z. Li et al.
CELL DEATH AND DIFFERENTIATION (2007)
Follicle stimulating hormone can act on receptors of other growth hormone
Annie N. Y. Cheung et al.
CARCINOGENESIS (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy
Steven Knapper et al.
BLOOD (2006)
Neuratrophin-regulated signalling pathways
Louis F. Reichardt
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities
Ming D. Qian et al.
JOURNAL OF NEUROSCIENCE (2006)
Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility
C. Q. Yang et al.
CARCINOGENESIS (2006)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Tyrosine kinase B receptor and its activated neurotrophins in ovaries from human fetuses and adults
S. Harel et al.
MOLECULAR HUMAN REPRODUCTION (2006)
Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells
K Nakamura et al.
CANCER RESEARCH (2006)
The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?
CJ Desmet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Neurotrophin system expression in human pulmonary carcinoid tumors
A Ricci et al.
GROWTH FACTORS (2005)
The neurotrophic receptor TrkB in anoikis resistance and metastasis: A prespective
TR Geiger et al.
CANCER RESEARCH (2005)
Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos
K Kawamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
RN Pearse et al.
BLOOD (2005)
Ovarian cancer metastasis: Integrating insights from disparate model organisms
H Naora et al.
NATURE REVIEWS CANCER (2005)
Angiogenic effects of BDNF examined
[Anonymous]
MOLECULAR THERAPY (2005)
Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrκB rescue of neuroblastoma cells from chemotherapy-induced cell death
ZJ Li et al.
CANCER RESEARCH (2005)
Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors
P Kermani et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor
JL Marshall et al.
INVESTIGATIONAL NEW DRUGS (2005)
TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary
A Paredes et al.
DEVELOPMENTAL BIOLOGY (2004)
VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma
HZ Chen et al.
GYNECOLOGIC ONCOLOGY (2004)
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
S Douma et al.
NATURE (2004)
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors
SD Undevia et al.
INVESTIGATIONAL NEW DRUGS (2004)
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
KW Cheng et al.
NATURE MEDICINE (2004)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment
A Edsjö et al.
LABORATORY INVESTIGATION (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: A novel approach to explain the field effect of ovarian cancer development in secondary Mullerian systems
J Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism
P Stoilov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Trk receptor tyrosine kinases: A bridge between cancer and neural development
A Nakagawara
CANCER LETTERS (2001)
Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication
B Chen et al.
BIOLOGICAL PSYCHIATRY (2001)
Autocrine expression of neurotrophins and their receptors in prostate cancer
F Satoh et al.
INTERNATIONAL JOURNAL OF UROLOGY (2001)
Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway
A Brunet et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
AST Wong et al.
ONCOGENE (2001)
Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival
A Haapasalo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor
A Eggert et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
The neurotrophin hypothesis for synaptic plasticity
AF Schinder et al.
TRENDS IN NEUROSCIENCES (2000)
Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo
MI Lin et al.
DEVELOPMENTAL BIOLOGY (2000)
Molecular biology of the VEGF and the VEGF receptor family
M Clauss
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)
分享论文
